Cargando…

mD-UPLC-MS/MS: Next Generation of mAb Characterization by Multidimensional Ultraperformance Liquid Chromatography-Mass Spectrometry and Parallel On-Column LysC and Trypsin Digestion

[Image: see text] For the past few years, multidimensional liquid chromatography-mass spectrometry (LC-MS) systems have been commonly used to characterize post-translational modifications (PTMs) of therapeutic antibodies (mAbs). In most cases, this is performed by fractionation of charge variants by...

Descripción completa

Detalles Bibliográficos
Autores principales: Oezipek, Saban, Hoelterhoff, Sina, Breuer, Simon, Bell, Christian, Bathke, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201819/
https://www.ncbi.nlm.nih.gov/pubmed/35545869
http://dx.doi.org/10.1021/acs.analchem.1c04450
_version_ 1784728398208172032
author Oezipek, Saban
Hoelterhoff, Sina
Breuer, Simon
Bell, Christian
Bathke, Anja
author_facet Oezipek, Saban
Hoelterhoff, Sina
Breuer, Simon
Bell, Christian
Bathke, Anja
author_sort Oezipek, Saban
collection PubMed
description [Image: see text] For the past few years, multidimensional liquid chromatography-mass spectrometry (LC-MS) systems have been commonly used to characterize post-translational modifications (PTMs) of therapeutic antibodies (mAbs). In most cases, this is performed by fractionation of charge variants by ion-exchange chromatography and subsequent online LC-MS peptide mapping analysis. In this study, we developed a multidimensional ultra-performance-liquid-chromatography-mass spectrometry system (mD-UPLC-MS/MS) for PTM characterization and quantification, allowing both rapid analysis and decreased risk of artificial modifications during sample preparation. We implemented UPLC columns for peptide mapping analysis, facilitating the linkage between mD-LC and routine LC-MS workflows. Furthermore, the introduced system incorporates a novel in-parallel trypsin and LysC on-column digestion setup, followed by a combined peptide mapping analysis. This parallel digestion with different enzymes enhances characterization by generating two distinct peptides. Using this approach, a low retentive ethylene oxide adduct of a bispecific antibody was successfully characterized within this study. In summary, our approach allows versatile and rapid analysis of PTMs, enabling efficient characterization of therapeutic molecules.
format Online
Article
Text
id pubmed-9201819
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-92018192022-06-17 mD-UPLC-MS/MS: Next Generation of mAb Characterization by Multidimensional Ultraperformance Liquid Chromatography-Mass Spectrometry and Parallel On-Column LysC and Trypsin Digestion Oezipek, Saban Hoelterhoff, Sina Breuer, Simon Bell, Christian Bathke, Anja Anal Chem [Image: see text] For the past few years, multidimensional liquid chromatography-mass spectrometry (LC-MS) systems have been commonly used to characterize post-translational modifications (PTMs) of therapeutic antibodies (mAbs). In most cases, this is performed by fractionation of charge variants by ion-exchange chromatography and subsequent online LC-MS peptide mapping analysis. In this study, we developed a multidimensional ultra-performance-liquid-chromatography-mass spectrometry system (mD-UPLC-MS/MS) for PTM characterization and quantification, allowing both rapid analysis and decreased risk of artificial modifications during sample preparation. We implemented UPLC columns for peptide mapping analysis, facilitating the linkage between mD-LC and routine LC-MS workflows. Furthermore, the introduced system incorporates a novel in-parallel trypsin and LysC on-column digestion setup, followed by a combined peptide mapping analysis. This parallel digestion with different enzymes enhances characterization by generating two distinct peptides. Using this approach, a low retentive ethylene oxide adduct of a bispecific antibody was successfully characterized within this study. In summary, our approach allows versatile and rapid analysis of PTMs, enabling efficient characterization of therapeutic molecules. American Chemical Society 2022-05-12 2022-06-14 /pmc/articles/PMC9201819/ /pubmed/35545869 http://dx.doi.org/10.1021/acs.analchem.1c04450 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Oezipek, Saban
Hoelterhoff, Sina
Breuer, Simon
Bell, Christian
Bathke, Anja
mD-UPLC-MS/MS: Next Generation of mAb Characterization by Multidimensional Ultraperformance Liquid Chromatography-Mass Spectrometry and Parallel On-Column LysC and Trypsin Digestion
title mD-UPLC-MS/MS: Next Generation of mAb Characterization by Multidimensional Ultraperformance Liquid Chromatography-Mass Spectrometry and Parallel On-Column LysC and Trypsin Digestion
title_full mD-UPLC-MS/MS: Next Generation of mAb Characterization by Multidimensional Ultraperformance Liquid Chromatography-Mass Spectrometry and Parallel On-Column LysC and Trypsin Digestion
title_fullStr mD-UPLC-MS/MS: Next Generation of mAb Characterization by Multidimensional Ultraperformance Liquid Chromatography-Mass Spectrometry and Parallel On-Column LysC and Trypsin Digestion
title_full_unstemmed mD-UPLC-MS/MS: Next Generation of mAb Characterization by Multidimensional Ultraperformance Liquid Chromatography-Mass Spectrometry and Parallel On-Column LysC and Trypsin Digestion
title_short mD-UPLC-MS/MS: Next Generation of mAb Characterization by Multidimensional Ultraperformance Liquid Chromatography-Mass Spectrometry and Parallel On-Column LysC and Trypsin Digestion
title_sort md-uplc-ms/ms: next generation of mab characterization by multidimensional ultraperformance liquid chromatography-mass spectrometry and parallel on-column lysc and trypsin digestion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201819/
https://www.ncbi.nlm.nih.gov/pubmed/35545869
http://dx.doi.org/10.1021/acs.analchem.1c04450
work_keys_str_mv AT oezipeksaban mduplcmsmsnextgenerationofmabcharacterizationbymultidimensionalultraperformanceliquidchromatographymassspectrometryandparalleloncolumnlyscandtrypsindigestion
AT hoelterhoffsina mduplcmsmsnextgenerationofmabcharacterizationbymultidimensionalultraperformanceliquidchromatographymassspectrometryandparalleloncolumnlyscandtrypsindigestion
AT breuersimon mduplcmsmsnextgenerationofmabcharacterizationbymultidimensionalultraperformanceliquidchromatographymassspectrometryandparalleloncolumnlyscandtrypsindigestion
AT bellchristian mduplcmsmsnextgenerationofmabcharacterizationbymultidimensionalultraperformanceliquidchromatographymassspectrometryandparalleloncolumnlyscandtrypsindigestion
AT bathkeanja mduplcmsmsnextgenerationofmabcharacterizationbymultidimensionalultraperformanceliquidchromatographymassspectrometryandparalleloncolumnlyscandtrypsindigestion